HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study.
Saved in:
| Title: | HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study. |
|---|---|
| Authors: | Qu, Kang1 (AUTHOR), Li, Ming-xi1 (AUTHOR), Yu, Peng2 (AUTHOR), Palotie, Aarno3,4 (AUTHOR), Pressman, Alice5 (AUTHOR), Belin, Andrea C.6 (AUTHOR), Bjornsdottir, Anna7 (AUTHOR), van den Maagdenberg, Arn M. J. M.8,9 (AUTHOR), Harder, Aster V. E.8,9 (AUTHOR), Winsvold, Bendik S.10,11,12 (AUTHOR), Müller-Myhsok, Bertram13 (AUTHOR), Cormand, Bru14 (AUTHOR), Ran, Caroline6 (AUTHOR), Northover, Carrie15 (AUTHOR), Kubisch, Christian16 (AUTHOR), van Duijn, Cornelia17 (AUTHOR), Nyholt, Dale R.18 (AUTHOR), Chasman, Daniel I.19,20 (AUTHOR), Posthuma, Danielle21 (AUTHOR), Lessel, Davor16 (AUTHOR) |
| Source: | Scientific Reports. 5/27/2024, Vol. 14 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
